Biological E. Limited (BioE) Current Affairs, GK & News

CORBEVAX’ gets DCGI approval for Clinical trials

The Drug Controller General of India (DCGI) gave approval to another indigenous COVID-19 vaccine candidate called CORBEVAX for two clinical trials. Highlights Vaccine maker Biological E received approval to conduct phase two and three clinical trials on children between five to eighteen years of age. Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council ..

Month: 

Category: 

Topics: